Competition Bureau advances investigation into NuvoCare’s weight loss claims

January 7, 2022 – GATINEAU, QC – Competition Bureau

The Competition Bureau has obtained a court order to advance an ongoing investigation into weight loss claims made by NuvoCare Health Sciences Inc. about certain natural health products. Those products include WeightOFF Max!, Forskolin+ and Forskolin Nx.

The order granted by the Federal Court of Canada on January 5, 2022 requires NuvoCare to produce records and information relevant to the Bureau’s investigation.

The Bureau is investigating the marketing practices of NuvoCare under the deceptive marketing practices provisions of the Competition Act.

In May 2020, the Bureau and NuvoCare entered into a temporary consent agreement that prohibits the company from making certain weight loss related claims while the Bureau completes its investigation. This agreement remains in effect until the Bureau’s investigation is resolved.

The Bureau strongly encourages anyone who suspects that a company or individual is making deceptive marketing claims to report it by using our online complaint form.

Source link

Related Posts